INTRODUCTION
The olfactory system furnishes sophisticated molecular and cellular mechanisms for reception, discrimination, and internal representation of information carried by an immense number of odor molecules in the external world. To achieve this feat, olfactory sensory neurons (OSNs) in the olfactory epithelium (OE) are destined to obey two basic principles during their unique differentiation process. First, individual OSNs select only one OR gene for expression from a repertoire of $1000 genes in mice, being tuned to a range of odor ligands with shared structural features that can bind and activate the expressed OR (Chess et al., 1994; Malnic et al., 1999; Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . Second, OSNs expressing a given OR project and converge their axons onto a few topographically fixed glomeruli among $2000 glomeruli spatially arranged on the surface of the olfactory bulb (OB), resulting in establishment of the ''odor map'' in OB (Vassar et al., 1994; Ressler et al., 1994; Mombaerts et al., 1996; Mori et al., 1999 Mori et al., , 2006 .
Thus, we currently have a wealth of knowledge on the pattern of olfactory axon wiring and the representation of odor information on OB odor map. So far, several guidance systems have been identified that play distinct roles in step-wise processes of olfactory axon projection from OE to OB in mice and zebrafish, including Cxcl12/Cxcr4, Robo/Slit, neuropilin/semaphorin, Eph/ ephrin, and Kirrel2/3 (Miyasaka et al., 2005 (Miyasaka et al., , 2007 Schwarting et al., 2000; Walz et al., 2002; Taniguchi et al., 2003; Imai et al., 2006; Cutforth et al., 2003; Serizawa et al., 2006) . However, the precise molecular mechanisms underlying the formation and maintenance of glomerular targeting still remain to be elucidated.
BIG-2 (contactin-4) is a glycosylphosphatidylinositol (GPI)-anchored axonal glycoprotein with six immunoglobulin (Ig)-like domains and four fibronectin-type III (FnIII) repeats ( Figure 1A ), belonging to the contactin subgroup of the Ig superfamily (Yoshihara et al., 1995) , also referred to contactin-4 (Zeng et al., 2002; Hansford et al., 2003) . BIG-2 shows a unique expression pattern in neuron type-and developmental stage-specific manners in various regions of the nervous system (Yoshihara et al., 1995) . In the present study, we investigated the expression of BIG-2 in the mouse olfactory system and found the mosaic pattern of BIG-2 protein expression among glomeruli. The expression level of BIG-2 closely correlated with the OR choice in individual OSNs. Furthermore, in BIG-2-deficient mice, olfactory axons frequently mistargeted onto multiple ectopic glomeruli, suggesting a crucial role of BIG-2 in the establishment of precise odor map in OB.
RESULTS

Expression of BIG-2 in a Subset of OSNs
In the course of immunohistochemical staining of mouse brain sections with antibodies against various cell recognition and axon guidance molecules, we noticed the strong expression of BIG-2 protein in the olfactory nerve layer and glomerular layer of OB. This preliminary finding prompted us to investigate detailed localization and physiological function of BIG-2 in the primary olfactory system.
In situ hybridization analysis of coronal sections of 6-week-old mouse heads at different anteroposterior levels showed that BIG-2 mRNA was widely expressed throughout the OE as well as in the vomeronasal organ ( Figures 1B-1D) . A higher magnification of the OE section revealed that BIG-2 mRNA was present in a subset of OSNs, but not in the sustentacular cells or the basal cells ( Figure 1E ). BIG-2-negative OSNs (black asterisks in Figure 1E) were intermingled with BIG-2-positive OSNs (white asterisks in Figure 1E ) in OE.
Next, the localization of BIG-2 protein was examined by immunohistochemistry with anti-BIG-2 antibody. BIG-2 protein was abundantly present in axons of OSNs but was almost absent from their dendrites and cell bodies ( Figure 1F ), which is a characteristic pattern of subcellular localization for most of GPIanchored neuronal proteins (Faivre-Sarrailh and Rougon, 1997) . BIG-2-positive axon bundles were observed throughout OE, similar to NCAM-positive axons ( Figures 1F-1H) . A higher magnification of triple-labeled axon bundles with antibodies against BIG-2, NCAM, and OCAM revealed that BIG-2-positive fibers ( Figures 1I and 1L-1N ) constitute a subpopulation, but not all, of axon bundles of OSNs, which partially overlaps but is distinct from a population of NCAM-positive fibers ( Figures 1J, 1L, and  1N ). The expression pattern of BIG-2 did not correspond to the olfactory zones whose boundary (between zone 1 and 2) can be evidently delineated by OCAM-negative and -positive axons (Figures 1K, 1M, and 1N; Yoshihara et al., 1997) . These results indicate that BIG-2 is expressed by a subset of OSNs with no relation to the zonal organization of OE.
Mosaic Pattern of BIG-2 Protein Expression among OB Glomeruli
To investigate the glomerular targeting patterns of BIG-2-positive and -negative axons, we performed immunohistochemical analysis of BIG-2 expression in OB sections from 6-week-old mice. A parasagittal section containing the glomerular sheet of the medial OB showed that individual glomeruli are labeled at different intensities with anti-BIG-2 antibody. Strongly BIG-2-positive glomeruli were intermingled with weakly BIG-2-positive and BIG-2-negative glomeruli on the surface of OB, whereas almost all the glomeruli displayed a similar level of NCAM expression (Figures 2A-2C ). The distribution pattern of glomeruli positive for BIG-2 was completely different from those for OCAM and neuropilin-1 (NP-1) ( Figures 2D-2K ), indicating that BIG-2 expression does not relate to the dorsoventral axis defined by OCAM and the anteroposterior axis defined by NP-1 (Yoshihara et al., 1997; Nagao et al., 2000; Imai et al., 2006) .
We next examined the overall distribution of BIG-2-positive and -negative glomeruli in OB. Double-immunofluorescence labeling of OB coronal sections with anti-BIG-2 and anti-vesicular glutamate transporter 2 (VGluT2) antibodies clearly delineated BIG-2-positive and -negative glomeruli, revealing that the mosaic pattern of BIG-2 expression was observed at all anteroposterior levels of OB ( Figures 2L-2Q) . A three-dimensionally reconstructed OB map ( Figures 2R-2U ) showed a wide distribution of strongly BIG-2-positive glomeruli ( Figures 2R-2U , red) intermingled with weakly positive ( Figures 2R-2U , green) and negative glomeruli ( Figures 2R-2U, blue) . A careful observation, however, revealed that BIG-2-positive glomeruli were somehow clustered in several regions of OB: at the anterior tip, on the dorsal surface, on the lateral surface, and in the ventroposterior region. Also in the accessory olfactory bulb, BIG-2 displayed a mosaic pattern of expression among glomeruli with variable signal intensities ( Figures 2P and 2Q ). In addition, BIG-2 expression in a subpopulation of olfactory axons was already observed during embryonic development (see Figures S1A-S1L available online).
It has been reported that homophilic adhesion molecules, Kirrel2 and Kirrel3, and repulsive guidance partners, ephrin-A5 and EphA5, are expressed in complementary subsets of OSNs respectively and show distinct and mosaic patterns of expression among OB glomeruli (Cutforth et al., 2003; Serizawa et al., 2006) . To clarify their relationship with BIG-2, we performed triple-immunofluorescence labeling of OB sections with antibodies against BIG-2, Kirrel2, and ephrin-A5. All the three molecules showed mosaic staining of OB glomeruli (Figure 3 ). BIG-2-positive glomeruli partly overlap with Kirrel2-or ephrin-A5-positive glomeruli, but the overall distribution of positive glomeruli appeared different among the three molecules ( Figures  3A-3D ). Higher magnification revealed that individual glomeruli express different levels of BIG-2, Kirrel2, and ephrin-A5 ( Figures  3E-3H ). We quantified signal intensities of BIG-2, Kirrel2, and ephrin-A5 in glomeruli (n = 506 from three mice), plotted on scatter graphs ( Figures 3I and 3J ) and calculated the correlation coefficients (r values). The expression of BIG-2 in individual glomeruli showed no correlation with that of Kirrel2 (r = 0.12 ± 0.04; Figure 3I ). In contrast, there was a weak but significant positive correlation between BIG-2 and ephrin-A5 (r = 0.28 ± 0.12; Figure 3J ). Taking it into account that ephrin-A5 expression tends to be higher in OSNs with reduced neural activity (Serizawa et al., 2006) , it is likely that BIG-2 undergoes a similar regulation. These results imply a combinatorial code of axon guidance molecules that specifies the identities of individual glomeruli in OB. 
Correlation of BIG-2 Expression Level and OR Gene Choice in OSNs
Based on the above results indicating the different levels of BIG-2 expression on OSN axons and their terminations onto distinct glomeruli, we hypothesized that BIG-2 expression may correlate with OR gene choice by individual OSNs. To examine this possibility, we used specific antibodies against four well-characterized ORs (MOR28, mOR-EG, OR-I7, and mOR256-17; Araneda et al., 2000; Serizawa et al., 2000; Strotmann et al., 2004; Oka et al., 2006) for double-immunofluorescence labeling with anti-BIG-2 antibody on OB sections from 6-week-old mice.
MOR28 is expressed by OSNs in the ventral area of OE, which project their axons to two relatively large glomeruli in the ventroposterior region of OB, one on the medial side ( Figure 4B ) and the other on the lateral side ( Figure 4E ). When the same sections were labeled for BIG-2, the MOR28-positive glomeruli on both the medial and lateral sides showed a markedly high level of BIG-2 expression . A similar result was reproducibly obtained from six adult mice. In addition, a high level of BIG-2 expression was detected in MOR28-positive glomeruli even at postnatal day 7 (Figures S1M-S1R). These results suggest that the MOR28-positive OSNs always express BIG-2 protein at a high level.
The analysis was next expanded to other three ORs . Both the medial and lateral glomeruli positive for mOR-EG in the dorsal region of OB showed a moderate level of BIG-2 expression (Figures 4H and 4L) . In contrast, the intensity of BIG-2 expression was relatively low in glomeruli positive for mOR256-17 and OR-I7 on both the medial and lateral sides (Figures 4I, 4J, 4M, and 4N) . To correlate the BIG-2 and OR expression in OSNs, we quantified the expression levels of BIG-2 in individual glomeruli, ranked them in order, and plotted OR-positive glomeruli on the graph ( Figure 4O ). Consistently, MOR28 glomeruli were positive for BIG-2 very strongly, mOR-EG glomeruli moderately, and mOR256-17 and OR-I7 very weakly. Intensities of BIG-2 expression in individual OR-positive glomeruli were almost the same between the medial and lateral sides of OB ( Figure 4P ). These results demonstrate a close correlation between the BIG-2 expression level and the OR gene choice in OSNs.
To further confirm the correlation between BIG-2 and OR expressions in OSNs, we used H-MOR28-ires-tauECFP transgenic mice in which MOR28 and tauEYFP are ectopically expressed under the control of H elements in a large population of OSNs located in ventrolateral region of OE (Serizawa et al., 2003 (Serizawa et al., , 2006 . In the H-MOR28-ires-tauECFP transgenic mice, MOR28-positive olfactory axons innervated numerous ectopic glomeruli located in OB, all of which showed a very high level of BIG-2 expression ( Figure S2 ) similar to the endogenous MOR28 glomeruli (Figure 4 ). This result clearly demonstrates that MOR28-positive OSNs express the high level of BIG-2 consistently.
Neural Activity-Regulated Expression of BIG-2 Neural activity of OSNs regulates the expression levels of axon guidance molecules, Kirrel2/Kirrel3, and ephrin-A5/EphA5 (Serizawa et al., 2006) . To examine a possible involvement of neural activity in the regulation of BIG-2 expression, we carried out two types of experiments. In the first experiment, we used the mutant mice for the cyclic nucleotide-gated channel A2 subunit (CNGA2) gene (Brunet et al., 1996) . Because the CNGA2 gene is located on the X chromosome, the heterozygous female mice show mosaic expression of CNGA2 in OSNs through the process of random X inactivation (Zhao and Reed, 2001) . As a result, each OR-defined glomerulus is segregated into two compartments (or two glomeruli) that are innervated by either CNGA2-positive or -negative OSNs (Zheng et al., 2000) . We examined BIG-2, Kirrel2, and ephrin-A5 expression in the CNGA2 mutant mice at postnatal day 14 (Figures 5A-5E) and quantified the expression levels in individual glomeruli (Figures 5F-5H). As reported previously (Serizawa et al., 2006) , CNGA2-mediated neural activity regulated the expression of Kirrel2 positively and ephrin-A5 negatively ( Figures 5B-5E , 5G, and 5H). BIG-2 expression N) . Asterisks in (G) represent the MOR28-positive medial glomerulus that was used as the relative standard (100%) of BIG-2 signal intensity.
(O) Glomerulus ranking for BIG-2 expression levels and its correlation with OR expression. Intensities of BIG-2 expression were measured for 2842 glomeruli on immunostained OB sections (n = 12) from six mice and plotted in a descending rank order. Glomeruli positive for MOR28 (n = 12), mOR-EG (n = 12), mOR256-17 (n = 17), and OR-I7 (n = 13) are shown in pink, blue, yellow, and green, respectively. tended to be negatively influenced by the neural activity ( Figures  5A, 5B , and 5F), although the extent of regulation was much smaller than that of ephrin-A5 ( Figure 5H ). Next, we compared BIG-2 expression levels between CNGA2-positive and -negative mOR-EG glomeruli. We expected that either up-or downregulation of BIG-2 could be easily detected in mOR-EG glomeruli because of the moderate level of BIG-2 expression in wildtype mice (Figure 4 ). In the CNGA2 mutant mice, two adjacent CNGA2-positive and -negative mOR-EG glomeruli were observed on both the medial (Figures 5J-5L ) and lateral ( Figures 5N-5P ) sides of OB. The level of BIG-2 expression was significantly higher in the CNGA2-negative mOR-EG glomeruli (arrowheads) than the CNGA2-positive glomeruli (arrows) (Figures 5I-5P ).
In the second experiment, wild-type mice at postnatal day 2 were subjected to unilateral naris occlusion and analyzed by immunohistochemistry after 6 months to examine whether the reduced neural activity of OSNs may influence the BIG-2 expression level. Efficiency of the naris occlusion was validated by the loss of tyrosine hydroxylase (TH) immunoreactivity in the OB glomerular layer on the closed side ( Figure 5U ; Stone et al., 1990) , despite apparently normal glomerular innervation of olfactory marker protein (OMP)-positive sensory axons ( Figure 5V ). In agreement with the previous finding by Serizawa et al. (2006) , Kirrel2 and ephrin-A5 were dramatically downregulated and upregulated, respectively, on the olfactory axons, particularly in the olfactory nerve layer, on the closed side ( Figures 5R-5T , 5X, and 5Y). The open-and closed-side difference in BIG-2 expression levels on olfactory axons ( Figures 5Q and 5T ) appeared smaller than those of Kirrel2 and ephrin-A5 but proved to be significant by a statistical analysis for quantification of signal intensities in individual glomeruli ( Figure 5W ). These results indicate that the neural activity negatively regulates the expression of BIG-2.
Abnormal Glomerular Targeting of Olfactory Axons in BIG-2-Deficient Mice A variety of proteins belonging to the Ig superfamily play important roles as axon guidance molecules in the formation and maintenance of neural circuits in the nervous system (Yoshihara et al., 1991; Maness and Schachner, 2007) . By analogy, it is conceivable that BIG-2 protein expressed on a subset of OSN axons in an OR type-specific fashion may be involved in axonal guidance and targeting to specific glomeruli in OB. To investigate this possibility, we generated BIG-2-deficient mice by disrupting the exon 2 that encodes the N-terminal signal peptide of BIG-2 protein ( Figures 6A and 6B) . The absence of BIG-2 protein in the mutant mice was confirmed by both Western blot and immunohistochemical analyses ( Figure 6C ; data not shown). A gross anatomy and a layer organization of OE in BIG-2-deficient mice appeared normal, as assessed by Nissl staining ( Figures  6D-6G ). No apparent change was observed in the expression levels and patterns of other cell surface molecules, such as NCAM, OCAM, NP-1, NP-2, Kirrel2, and ephrin-A5, that are present in either all or subsets of OSN axons ( Figure 6C ; data not shown).
Based on the close correlation between the BIG-2 expression level and the OR gene choice (Figure 4 ), we assumed a putative function of BIG-2 in convergence and glomerular targeting of OSN axons expressing individual ORs. To corroborate this possibility, we investigated OB glomeruli representing individual ORs in detail by immunohistochemistry with antibodies against MOR28, mOR-EG, and OR-I7 in wild-type and BIG-2-deficient littermates (6-8 weeks). In wild-type mice, MOR28-positive OSNs innervated mostly a single glomerulus on both the medial and lateral sides of OB (90% of half-bulbs), while a small glomerulus ectopically targeted by MOR28-positive axons was observed in only 10% of half-bulbs ( Figure 6R ). In contrast, the BIG-2 deficiency resulted in more frequent appearance of ectopic MOR28 glomeruli (28% of half-bulbs; Figures 6H-6L and 6R). The average number of MOR28 glomeruli per halfbulb in BIG-2-deficient mice (1.3 ± 0.1) was significantly larger than that in wild-type mice (1.1 ± 0.1; Figure 6S ). Next, we examined glomerular targeting of OR-I7-positive OSNs and found more severe defects with abnormally multiple glomeruli ( Figures  6M-6Q ). Ectopically located small glomeruli were detected in 83% of half-bulbs in BIG-2-deficient mice, compared to 25% in wild-type mice ( Figure 6R ). The average numbers of OR-I7 glomeruli per half-bulb were 1.3 ± 0.2 in wild-type mice and 2.4 ± 0.3 in BIG-2-deficient mice ( Figure 6S) . Similarly, ectopically located mOR-EG glomeruli were more frequently observed in BIG-2-deficient mice (71% of half-bulbs) than in wild-type mice (42% of half-bulbs; Figure 6R ). The average numbers of mOR-EG glomeruli per half-bulb were 1.4 ± 0.1 in wild-type mice and 1.8 ± 0.1 in BIG-2-deficient mice ( Figure 6S ). There was no shift in the positions of OR-defined major glomeruli and no tendency in the relative positions of ectopic glomeruli along either the anteroposterior or dorsoventral axes in BIG-2-deficient mice (data not shown). A similar ectopic innervation to multiple glomeruli was observed for OR-I7-expressing OSNs in BIG-2-deficient mice as early as postnatal day 7 ( Figure S3 ). These results indicate that BIG-2 is required for convergence of OSN axons to proper target glomeruli in the OB.
Presence of Heterophilic BIG-2-Binding Partner on Olfactory Axons
To gain insight into the mode of BIG-2 action on olfactory axon convergence, we prepared a recombinant fusion protein consisting of mouse BIG-2 extracellular region and human placental alkaline phosphatase (BIG-2/AP) and performed an overlay assay on OB sections from adult wild-type and BIG-2-deficient mice. BIG-2/AP strongly bound onto the nerve layer and glomerular layer in OB of BIG-2-deficient mice in a mosaic fashion (Figure 7B) , whereas the BIG-2/AP binding was very weak on OB sections from wild-type mice ( Figure 7A ). This finding implies the presence of a binding partner of BIG-2 in glomeruli, which may be masked by endogenous BIG-2 in wild-type mice, but uncovered in BIG-2-deficient mice to be detectable by exogenous BIG-2/AP in the overlay assay. An alternative possibility would be that the expression of BIG-2-binding partner might be upregulated in the absence of BIG-2.
Intranasal irrigation of ZnSO 4 causes acute OE destruction that accompanies deafferentation of olfactory axons projecting to OB (Nadi et al., 1981; McBride et al., 2003) . Using this method, we tested whether the binding partner of BIG-2 is derived from OSNs or other types of cells in OB. A selective deafferentation of olfactory axons was confirmed by the loss of OMP immunoreactivity in glomeruli ( Figure 7F ). In contrast, the dendrites of mitral cells projecting into glomeruli were unaffected by ZnSO 4 treatment as revealed by immunostaining of protocadherin-21, a mitral cell marker (Figures 7D-7F ; Nakajima et al., 2001; Nagai et al., 2005) . ZnSO 4 -induced deafferentation of olfactory axons led to almost complete loss of the BIG-2/AP binding to glomeruli ( Figure 7C ). This result indicates that the BIG-2-binding molecule is located on axon terminals of OSNs, but not on dendrites of OB neurons, in glomeruli.
The mosaic pattern of BIG-2/AP-binding to OB glomeruli is reminiscent of different levels of endogenous BIG-2 expression among individual glomeruli. To correlate them, adjacent OB sections from BIG-2-deficient mice were subjected to OR immunohistochemistry and BIG-2/AP overlay assay. As mentioned above, MOR28 glomeruli are strongly positive for BIG-2, while OR-I7 glomeruli are very weakly positive (Figure 4) . In BIG-2-deficient mice, an intense binding of BIG-2/AP was observed in MOR28 glomeruli on both the medial and lateral sides ( Figures 7G, 7H , 7K, and 7L), whereas OR-I7 glomeruli showed little binding of BIG-2/AP ( Figures 7I, 7J, 7M, and  7N) . Thus, there appears to be a correlation among the OR gene choice, the BIG-2 expression level, and the BIG-2/AP binding intensity reflecting the expression level of a putative BIG-2-binding molecule.
DISCUSSION
The key conclusions of this study are as follows: (1) guidance molecule that mediates proper neuronal wiring in the mouse olfactory system. BIG-2: A Cell Adhesion Molecule of the Contactin Family BIG-2 belongs to the contactin subgroup of the Ig superfamily, which includes other five GPI-anchoring glyocoproteins: contactin, TAG-1, BIG-1, NB-2, and NB-3. They are closely related in structure harboring the same domain organization but show differential patterns of expression in the developing and adult brains. Based on phenotypes of knockout mice, crucial roles of several members of this subgroup have been reported in various aspects of neural development and functions. For example, contactin and TAG-1 are essential for the molecular organization of paranode and juxtaparanode of myelinated fibers, respectively (Boyle et al., 2001; Traka et al., 2003) . Contactin-deficient mice display abnormal cerebellar architecture accompanying severe ataxia (Berglund et al., 1999) and impaired long-term depression in the hippocampus (Murai et al., 2002) . TAG-1 is required for proper neuronal migration of the precerebellar nuclei (Denaxa et al., 2005) . NB-2-deficient mice show aberrant responses to acoustic stimuli (Li et al., 2003) . NB-3 deficiency leads to impaired motor coordination . In terms of the olfactory system, however, there was no report on functional analysis of the contactin subgroup members. In this study, we identified BIG-2 as an axon guidance molecule required for establishment of the olfactory neural circuitry.
The Ig-like and FnIII-like domains of contactin and TAG-1 exert binding activities to various types of molecules. Contactin interacts with the L1 subgroup members of the Ig superfamily (L1, NrCAM, neurofascin), the extracellular matrix molecules (tenascin-R and -C), receptor tyrosine phosphatase b/phosphacan, voltage-gated sodium channels, Notch, and Caspr/paranodin (Falk et al., 2002) . TAG-1 binds heterophilically to L1, NrCAM, tenascin-C, and NCAM, and also homophilically to TAG-1 itself (Rutishauser, 2000) . In the BIG-2/AP-overlay experiment on OB sections from BIG-2-deficient mice, we have demonstrated the presence of heterophilic binding partner of BIG-2 in glomeruli. Interestingly, BIG-2/AP bound strongly to MOR28 glomeruli (high BIG-2) and weakly to OR-I7 glomeruli (low BIG-2). Thus, the putative counter-receptor for BIG-2 shows a mosaic pattern of expression correlated with that of BIG-2 itself. In addition, ZnSO 4 -induced deafferentation experiment revealed that the putative counter-receptor for BIG-2 is present on OSN axons. Taken together, these results suggest that the heterophilic adhesion between BIG-2 and its counter-receptor may mediate olfactory axon fasciculation and glomerular targeting in close relation to the OR gene choice in OSNs. Identification and characterization of the heterophilic BIG-2-binding partner will provide a deeper mechanistic insight into the axon-axon interaction mediated by BIG-2.
As well as the olfactory system, BIG-2 is present in different subsets of neuronal types in various brain regions (Yoshihara et al., 1995) . For example, BIG-2 is highly expressed in granule cells in the anterior folia (lobules 1-6) and Purkinje cells in the lobules 9 and 10 in the cerebellum. In the hippocampus, BIG-2 is expressed strongly in the CA1 pyramidal cells but only weakly in the CA3 pyramidal cells and the dentate gyrus granule cells. Thus, it is likely that an axon guidance molecule BIG-2 plays functional roles in the formation and maintenance of neural circuits also in these regions. Recently, human BIG-2 (CNTN4) locus (3p26.2-3p26.3) was identified as a candidate gene responsible for 3p deletion syndrome characterized by developmental delay, postnatal growth retardation, and dysmorphic features (Fernandez et al., 2004) and spinocerebellar ataxia type 16 (SCA16) characterized by cerebellar degeneration (Miura et al., 2006) . With reference to the phenotypes of these human disorders that are possibly caused by BIG-2 gene mutations, detailed histological and behavioral analyses of BIG-2-deficient mice are now in progress to elucidate the Various axon guidance molecules appear to be involved in the process of olfactory axon pathfinding from OE to OB. We propose a four-step hierarchical model for the formation of neural circuitry in the primary olfactory system. (1) Initial outgrowth of olfactory axons from OE is regulated by the permissive effect of chemokine Sdf-1 (Cxcl12) which acts on its receptor Cxcr4 transiently expressed in the developing OSNs of zebrafish (Miyasaka et al., 2007) . (2) Navigation of olfactory axons toward OB is partly directed by the chemorepellent Slit and its receptor Robo in zebrafish (Miyasaka et al., 2005) . (3) Coarse targeting of olfactory axons to appropriate domains of OB appears to be mediated by the repulsive interactions between neuropilins and their ligands semaphorins (Schwarting et al., 2000; Walz et al., 2002; Taniguchi et al., 2003) . In particular, spontaneous OR/Gs-derived cAMP signals control the expression level of NP-1 that directs olfactory axon projection along the anteroposterior axis of OB (Imai et al., 2006) . (4) Convergence of olfactory axons onto target glomeruli is controlled by combinatorial actions of guidance molecules including BIG-2, Kirrel2, Kirrel3, ephrin-A5, and EphA5 (Cutforth et al., 2003; Serizawa et al., 2006) .
The axonal convergence to specific glomeruli is apparently the most complex among the four steps. This process involves a combination of three different modes of axon-axon interactions: heterophilic adhesion, homophilic adhesion, and repulsion. From this study, the Ig superfamily molecule BIG-2 is likely to mediate the glomerular convergence of olfactory axons through the heterophilic binding to its unknown counter-receptor. Kirrel2 and Kirrel3, the two closely related members of the Ig superfamily, are expressed in complementary subsets of OSNs and respectively mediate the glomerular targeting through their homophilic-binding properties (Serizawa et al., 2006 ). In contrast, ephrin-A5 and EphA5 that are expressed also in a complementary fashion exert their functions through the repulsive activity (Cutforth et al., 2003; Serizawa et al., 2006) .
The expression levels of these axon guidance molecules are closely correlated with the OR gene choice in individual OSNs and are regulated by neural activity. Interestingly, the CNGA2-deficient mouse and unilateral naris occlusion experiments revealed that the properties of neural activity dependence are different among the molecules in terms of the direction and the extent. Kirrel2 and EphA5 are highly expressed in high-activity OSNs, while BIG-2, ephrin-A5, and Kirrel3 show higher levels in low-activity OSNs. The expression of ephrin-A5 is dramatically influenced by the neural activity, while BIG-2 is regulated to a lesser extent. Such a difference may serve to generate the variability in expression levels of axon guidance molecules in individual OSNs with different types of OR genes. Taken together, the combinatorial codes of axon guidance molecules defined by neural activity may be a crucial mechanism underlying the selective convergence of olfactory axons to target glomeruli ( Figure 8A ).
In BIG-2-deficient mice, many olfactory axons aberrantly projected to ectopic destinations in OB. The degree of impairment in axon targeting varied among three OR types. Unexpectedly, the abnormal targeting was most obvious for OR-I7-positive axons that normally express a relatively low level of BIG-2, whereas the abnormality was relatively mild for MOR28-positive axons that normally display the highest BIG-2 expression. Two notions may account for this apparently contradictory result as follows. First, the stability of glomeruli appears different among individual ORs. There are several reports demonstrating that some OR-defined glomeruli are ''labile'' with variability of their positions and numbers across different OBs (Strotmann et al., 2000; Schaefer et al., 2001; Oka et al., 2006) . We assume that MOR28 glomeruli may be relatively ''stable,'' while OR-I7 glomeruli may be very ''labile,'' leading to such a phenotypic variability of axon mistargeting in BIG-2-deficient mice. Second, the disruption of BIG-2 gene results in a decrease of the combinatorial code repertoire of guidance molecules on olfactory axons. Because of the loss of BIG-2, several distinct OR-defined OSNs that normally express different levels of BIG-2 in wild-type mice should present a similar combinatorial code of other axon guidance molecules. Thus, it will become difficult for individual axons to recognize their fellow travelers reaching the same target glomeruli in BIG-2-deficient mice ( Figure 8B ). In summary, BIG-2 is required for sound projection of olfactory axons to target glomeruli in combination with other axon guidance molecules.
EXPERIMENTAL PROCEDURES In Situ Hybridization
In situ hybridization was performed as described previously .
Antibody Production
Anti-BIG-2 antibody was produced by immunizing guinea pigs with recombinant BIG-2/Fc fusion protein consisting of rat BIG-2 extracellular region and human IgG 1 Fc region. Antibodies against mouse MOR-28, mOR-EG, and OR-I7 were produced by immunizing guinea pigs with keyhole limpet hemocyanin-conjugated synthetic peptides corresponding to the carboxyl-terminal 20 amino-acid residues of ORs (MOR28, NEDMKSALKKLIRRKEGKEK; mOR-EG, RNKDVKDTVKKIIGTKVYSS; OR-I7, RTLHLAQGQDANTKKSSRDG). Individual OR-directed antibodies intensely labeled cilia, cell bodies, and axon terminals of OSNs, as reported previously Strotmann et al., 2004) . Anti-protocadherin-21 antibody was produced by immunizing rabbits with a synthetic peptide corresponding to the carboxyl-terminal 20 aminoacid residue of mouse protocadherin-21 (LVSELKQKFEKKSLDNKAYI). This antibody specifically labeled soma and dendrites of mitral cells.
Immunohistochemistry Immunohistochemistry was performed as described previously . Primary antibodies used are as follows: guinea pig anti-BIG-2/Fc (1:1000); goat anti-contactin-4/BIG-2 (1:500, R&D Systems); rat anti-NCAM (1:500, Chemicon); rabbit anti-OCAM (1:1000) (Yoshihara et al., 1997) ; goat anti-NP-1 (1:400, R&D Systems); goat anti-NP-2 (1:400, R&D Systems); rabbit anti-VGluT2 (1:700, a gift from Dr. Takeshi Kaneko at Kyoto University) (Kaneko et al., 2002) ; rabbit anti-Kirrel2 (1:2000, a gift from Dr. Hitoshi Sakano at The University of Tokyo) (Serizawa et al., 2006) ; goat anti-ephrin-A5 (1:75, R&D Systems); guinea pig anti-MOR28 (1:1000); guinea pig anti-mOR-EG (1:1000); guinea pig anti-OR-I7 (1:5000); rabbit antimOR256-17 (1:1000, a gift from Dr. Heinz Breer at Hohenheim University) (Strotmann et al., 2004) ; rabbit anti-CNGA2 (1:200, Alomone Labs); rabbit anti-TH (1:300, Chemicon); goat anti-OMP (1:10000, a gift from Dr. Frank L. Margolis at University of Maryland); rat anti-GFP (1:1000, Nacalai Tesque). Cy3-and Cy5-conjugated secondary antibodies were purchased from Jackson ImmunoResearch. Alexa 488-conjugated secondary antibodies were purchased from Molecular Probes.
For triple-immunofluorescence labeling of BIG-2, Kirrel2, and ephrin-A5 proteins, OB sections were treated as follows: (1) a mixture of guinea pig anti-BIG-2 and goat anti-ephrin-A5 antibodies, (2) a mixture of anti-guinea pig and anti-goat secondary antibodies, (3) antigen-retrieval medium (HistoVT One, Nacalai Tesque), (4) a mixture of guinea pig anti-BIG-2, goat anti-ephrin-A5, and rabbit anti-Kirrel2 antibodies, (5) a mixture of anti-guinea pig, antigoat, and anti-rabbit secondary antibodies.
Image Analysis
Fluorescent digital images were captured using Axioplan epifluorescence microscopy (Carl Zeiss) equipped with DP70 CCD camera (Olympus) and Fluoview FV1000 confocal laser scanning microscopy (Olympus). To quantify the expression levels of BIG-2, Kirrel2, and ephrin-A5 in each glomerulus, the mean pixel intensity within the region surrounded by the periglomerular cell nuclei was measured using the public domain ImageJ program (NIH). A three-dimensional glomerular map of BIG-2 expression was reconstructed from 40 sections using DeltaViewer 2.1 software.
Mutant Mice
BIG-2-deficient mice were generated with a standard gene-targeting method. An 8.7 kb genomic DNA fragment containing the exon 2 of mouse BIG-2 gene was isolated and subcloned into a plasmid with diphtheria toxin A gene as a negative selection marker. The initiation methionine codon (ATG) of BIG-2 gene was mutated into a stop codon (TAG) using GeneEditor in vitro SiteDirected Mutagenesis System (Promega). A tandem cassette consisting of the pgk-neo positive-selection marker and the transcription/translation stop signal was inserted into a HindIII site in the exon 2. Electroporation into a 129/SvEv mouse ES cell line followed by G418 selection resulted in one positive homologous recombinant out of 576 clones as determined by PCR screening and Southern blot analysis. Chimeric C57B/6 males that transmitted the mutant allele were obtained, backcrossed with C57B/6 mice nine times, and used for the experiments. The following primers were used for genotyping BIG-2 progeny: 5 0 -aaaggcagatatgcagagaccataaggag-3 0 and 5 0 -ttcatcactcct gaatcacacatgtcagg-3 0 for the wild-type allele and 5 0 -tggtagatggatcgatggcaaa catgtccc-3 0 and 5 0 -ggttcacagaaggctcatggaaacagtc-5 0 for the mutant allele.
Thirty-five cycles of PCR (96 C for 45 s, 61 C for 30 s, 72 C for 105 s) were performed with ExTaq HS DNA polymerase (Takara).
The H-MOR28-ires-tauECFP transgenic mice (Serizawa et al., 2003 (Serizawa et al., , 2006 were generous gifts from Dr. Hitoshi Sakano (The University of Tokyo). The CNGA2 mutant mice were purchased from The Jackson Laboratory.
Unilateral Naris Occlusion
Unilateral naris occlusion was performed on postnatal day 2 mice as described previously (Philpot et al., 1997 ) and analyzed after 6 months for immunohistochemistry.
Western Blot Analysis OB homogenates were prepared from adult BIG-2 +/+, +/À, and À/À mice. Western blot analysis was performed as described previously (Yoshihara et al., 1991) . BIG-2 protein on blots could be detected with guinea pig anti-BIG-2 antibody only under a nonreducing condition. Primary antibodies used are as follows: guinea pig anti-BIG-2/Fc (1:5000); rat anti-NCAM (1:1000, Chemicon); rabbit anti-OCAM (1:2000); goat anti-NP-1 (1:1000, R&D Systems), goat anti-NP-2 (1:1000, R&D Systems); rabbit anti-Kirrel2 (1:10000). Horseradish peroxidase-conjugated secondary antibodies were purchased from Jackson ImmunoResearch. Protein bands were visualized with a chemiluminescence reaction kit (ECL Plus Western Blotting Detection System, Amersham) and an image analysis system (LAS-1000, Fujifilm).
BIG-2/AP Overlay Assay BIG-2/AP fusion plasmid, pEF-BIG-2/AP, was constructed by inserting cDNA encoding the extracellular region of mouse BIG-2 into pEF-AP vector which harbors human elongation factor-1a promoter (Mizushima and Nagata, 1990) and human placental alkaline phosphatase (Cheng and Flanagan, 1994) . pEF-BIG-2/AP was transfected into HEK293-F cells (FreeStyle 293-F cells, Invitrogen) and BIG-2/AP protein in the culture supernatant was concentrated using Centriprep (Millipore). AP overlay assay was performed on paraformaldehyde-fixed OB sections essentially as described previously (Flanagan et al., 2000) .
Zinc Sulfate Irrigation
Intranasal irrigation of ZnSO 4 was performed on adult mice as described previously (McBride et al., 2003) and analyzed after 14 days for immunohistochemistry and BIG-2/AP overlay assay.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www. neuron.org/cgi/content/full/57/6/834/DC1/.
